Cargando…
Long‐term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration
BACKGROUND: Torsemide use for congestive heart failure (CHF) has been reported, but prescription frequency is unknown. Commercially available tablet sizes in North America limit dosing precision, indicating a need to evaluate its strength and stability in suspension. OBJECTIVES: To determine the fre...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697182/ https://www.ncbi.nlm.nih.gov/pubmed/28913839 http://dx.doi.org/10.1111/jvim.14819 |